NCT02233881View on ClinicalTrials.gov

Post-marketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease

CompletedOBSERVATIONAL
Enrollment

4,222

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

November 30, 2001

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Atrovent® - inhalets

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02233881 - Post-marketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter